跳至主要内容
临床试验/NCT01565811
NCT01565811已完成不适用

Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis

Gachon University Gil Medical Center1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
complication rate

研究概览

简要总结

Objective: To evaluate the role of regional lymphadenectomy in patients with colorectal cancer liver metastasis. Background: Lymph node status is 1 of the most important prognostic factors in oncologic surgery; however, the role of lymph node dissection remains unclear for colorectal cancer liver metastasis.

详细描述

Lymph node status is a definite prognostic factor in oncologic surgery and significantly affects long-term survival, as reported by the tumor staging system of the International Union Against Cancer (IUCC), which is the most widespread classification of malignant tumors worldwide. Regional lymphadenectomy is already the standard procedure that completes hepatic resection in the case of carcinoma arising from the extrahepatic bile duct. However, the indication, extent, and role of lymph node excision are still a matter of discussion, and no clear guidelines exist in patients with colorectal cancer liver metastasis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • first hepatectomy;
  • age <75 years;
  • absence of severe cardiovascular,pulmonary, or other associated diseases;
  • absence of other malignant disease;
  • absence of distant metastases secondary to colorectal cancer other than liver metastases (except a solitary peritoneal tumor that could be completely resected during hepatectomy); and
  • complete resection of liver metastases confirmed during surgery.

排除标准

  • patient who refuses perihepatic lymphadnectomy
  • medical condition in which surgery cannot be tolerated

结局指标

主要结局

complication rate

时间窗: within 3months

次要结局

  • To evaluate prognostic significance of perihepatic LN involvement with overall survival and disease free survival(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Won-Suk Lee

Assistant Professor

Gachon University Gil Medical Center

研究点 (1)

Loading locations...

相似试验